A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2001
11/01/2001	WO2001080830A2 Pharmacotherapeutic process and composition for central nervous system disorders
11/01/2001	WO2001080829A2 Taste masking coating composition
11/01/2001	WO2001080828A2 Improved water-insoluble drug particle process
11/01/2001	WO2001080827A2 Salicylic acid acne spray formulations and methods for treating acne with same
11/01/2001	WO2001080826A2 Taste masking coating composition
11/01/2001	WO2001080825A2 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
11/01/2001	WO2001080824A2 Dual mechanism timed release dosage forms for low dose drugs
11/01/2001	WO2001080823A2 Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients
11/01/2001	WO2001080822A2 Effervescent granules and methods for their preparation
11/01/2001	WO2001080819A1 Cosmetic or dermatological cream composition, the preparation and the use thereof
11/01/2001	WO2001080797A1 Medicated wrap
11/01/2001	WO2001080796A1 Minimizing adverse experience associated with oxybutynin therapy
11/01/2001	WO2001080633A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
11/01/2001	WO2001080619A2 Pharmaceutical composition containing citalopram
11/01/2001	WO2001068745A8 Liquid crystalline polymers
11/01/2001	WO2001042231A3 Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors
11/01/2001	WO2001041762A3 Valdecoxib compositions
11/01/2001	WO2001041761A3 Valdecoxib compositions
11/01/2001	WO2001036609A8 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
11/01/2001	WO2001036608A8 Reversibly inactivated acidified plasmin
11/01/2001	WO2001035974A3 Aplidine treatment of cancers
11/01/2001	WO2001030380A3 Methods and compositions for treatment of keratoconus using protease inhibitors
11/01/2001	WO2001030372A3 Pharmaceutical agent preparations
11/01/2001	WO2001029189A3 Synthetic substrate for tissue formation
11/01/2001	WO2001029046A3 A salt of morphine
11/01/2001	WO2001028570A3 Zinc lactate lozenges and uses thereof
11/01/2001	WO2001028356A3 Food supplement for increasing lean mass and strength
11/01/2001	WO2001022946A3 Method and device for dispensing adhesive laminate segments
11/01/2001	WO2001017480A3 Methods and compositions for preventing and treating urinary tract disorders
11/01/2001	WO2001014318A3 New effectors of dipeptidyl peptidase iv for topical use
11/01/2001	WO2001013924A8 Novel compositions for controlled release of a biologically active agent, and the preparation thereof
11/01/2001	WO2001012233A3 Sustained release formulation of a peptide
11/01/2001	WO2000044333A3 Novel injectable antimalarial compositions of artemisinin
11/01/2001	WO1999013816A3 Liposomal camptothecin formulations
11/01/2001	US20010037104 Methods and apparatus for using controlled heat to regulate transdermal and controlled release delivery of fentanyl, other analgesics, and other medical substances
11/01/2001	US20010037083 Method and apparatus to control drug therapy dosages in an implantable pump
11/01/2001	US20010037006 Introducing monomeric 2-hydroxyethyl methacrylate containing ethylene glycol dimethacrylate impurities in the range of 0.05 to 0.1% by weight with hydroxybutyl acrylate into a solution of water and alcohol, copolymerizing; gel-free
11/01/2001	US20010036966 Hardly soluble drug together with water-soluble polymer; does not undergo aggregation of dispersed particles or caking; useful as a parenteral preparation, eye drops, nasal drops
11/01/2001	US20010036962 Self-emulsifying systems containing anticancer medicament
11/01/2001	US20010036960 Carvedilol-lipophilic solutions
11/01/2001	US20010036959 Carvedilol-hydrophilic solutions
11/01/2001	US20010036954 Use of calcium channel blocker optionally in the presence of a anti-hypertensive agent
11/01/2001	US20010036931 Inhibition of cell-cell binding by lipid assemblies
11/01/2001	US20010036920 Method for treating papillomavirus infections
11/01/2001	US20010036919 Preventing airway mucus production by administration of EGF-R antagonists
11/01/2001	US20010036918 Pharmaceutical composition
11/01/2001	US20010036916 Insoluble insulin compositions
11/01/2001	US20010036898 Activating catalyst; reducing by-products
11/01/2001	US20010036495 Enhanced food products
11/01/2001	US20010036489 Anti-wrinkle preparation and method of reducing wrinkles in facial skin and neck
11/01/2001	US20010036483 Administering drug to localized region of human patient's body surface in combination with hydroxide releasing agent applied to body surface
11/01/2001	US20010036481 Modulation of release from dry powder formulations
11/01/2001	US20010036480 Particulate drug-containing products and method of manufacture
11/01/2001	US20010036479 Having preferred particle size distribution characteristics; antidiabetic agent
11/01/2001	US20010036478 Core formulation
11/01/2001	US20010036477 Oral administering
11/01/2001	US20010036476 Bioavailability; sustained release
11/01/2001	US20010036475 Pharmaceutical tablets
11/01/2001	US20010036473 Enteric and colonic delivery using HPMC capsules
11/01/2001	US20010036472 Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
11/01/2001	US20010036471 Hard capsules comprising polymers of vinyl esters and polyethers, their use and production
11/01/2001	US20010036470 Delivery and activation through liposome incorporation of diaminocyclohexane platinum(ii) complexes
11/01/2001	US20010036469 Opiate antagonist implant and process for preparation therefor
11/01/2001	US20010036468 Soft chewable multivitamin tablet comprising separated active ingredients
11/01/2001	US20010036464 Carrier mixture of starch, oil, alcohol, sugar, water and salt
11/01/2001	US20010036463 Transcutaneous immunization for large particulate antigens
11/01/2001	US20010036454 Transfection of lung tissue
11/01/2001	US20010036450 Oil in water emulsions
11/01/2001	US20010036449 Therapy for dry eye
11/01/2001	US20010036445 Method of making chewing gum containing colloidal bismuth subcitrate
11/01/2001	US20010036444 Anticancer agents
11/01/2001	US20010036443 Respiratory system disorders
11/01/2001	CA2407515A1 A particulate complex for administering nucleic acid into a cell
11/01/2001	CA2407154A1 Zero order release and temperature-controlled microcapsules and process for the preparation thereof
11/01/2001	CA2407074A1 Compositions and methods for in vivo delivery of polynucleotide-based therapeutics
11/01/2001	CA2406949A1 Use of particulate vectors in immunomodulation
11/01/2001	CA2406659A1 Transparent liquid composition
11/01/2001	CA2406067A1 Compositions comprising the combination of a bile acid and a fibrate for use in therapies for hyperlipidaemia-associated disorders
11/01/2001	CA2405194A1 Process for producing microspheres
11/01/2001	CA2404998A1 Cytotoxic agents
10/2001
10/31/2001	EP1149572A1 Solid preparation coated with a film coating layer having two or more different colors
10/31/2001	EP1149117A1 Novel alkanolamide-free thickening latex
10/31/2001	EP1149093A1 4-aryloxindoles as inhibitors of jnk protein kinases
10/31/2001	EP1149090A1 Potassium salt of ($i(s))-omeprazole
10/31/2001	EP1149069A1 Phenylglycine derivatives
10/31/2001	EP1149066A1 Method of preparing alkylated salicylamides
10/31/2001	EP1149057A1 Biodegradable glass compositions and methods for radiation therapy
10/31/2001	EP1148937A1 Microemulsions, method for preparing same and uses
10/31/2001	EP1148923A1 Removable filter for slurry hydrocarbon synthesis process
10/31/2001	EP1148905A2 Compressed air inhaler for pulmonary application of liposomal powder aerosols and powder aerosols suitable therefor
10/31/2001	EP1148902A1 Method of enhancing needleless transdermal powdered drug delivery
10/31/2001	EP1148895A1 Thermo-reversible polymer for intralumenal implant
10/31/2001	EP1148883A1 Method for treatment of headache
10/31/2001	EP1148872A1 Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor
10/31/2001	EP1148871A1 Core tablet for controlled release of gliclazide after oral administration
10/31/2001	EP1148870A1 Anti-plaque emulsions and products containing same
10/31/2001	EP1148869A1 Method for regulating a chemical valve
10/31/2001	EP1148793A1 Method of preparing microparticles of phytosterols or phytostanols
10/31/2001	EP1058540B1 Oral pellet with immediate release comprising glycerides subjected to polyglycolysis, method for making same
10/31/2001	EP0980248B1 Improvements in or relating to long-acting antimicrobials

1 ... 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 2366 2367 2368 ... 2991